{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:18:55Z","timestamp":1790432335113,"version":"4.1.0"},"reference-count":87,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2013.0319","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T05:25:18Z","timestamp":1525238718000},"source":"Crossref","is-referenced-by-count":34,"title":["Malignant Pleural Mesothelioma"],"prefix":"10.3238","author":[{"given":"Volker","family":"Neumann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"L\u00f6seke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix J. F.","family":"Herth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Tannapfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2013,5,3]]},"reference":[{"key":"10.3238\/arztebl.2013.0319_ref1","doi-asserted-by":"crossref","unstructured":"Delgermaa V, Takahashi K, Park E, Le G, Hara T, Sorahan T: Global mesothelioma deaths reported to the World Health Organisation between 1994 and 2008. Bull World Health Organ 2011; 89: 716\u201324","DOI":"10.2471\/BLT.11.086678"},{"key":"10.3238\/arztebl.2013.0319_ref2","unstructured":"Woitowitz H, Hillerdal G, Galvarezos A, Bergh\u00e4user K, R\u00f6delsperger K, J\u00f6ckel K: Risiko und Einflussfaktoren des diffusen malignen Mesothelioms (DMM) Forschungsberichtsreihe FB 698 Bundesanstalt f\u00fcr Arbeitsschutz 1993."},{"key":"10.3238\/arztebl.2013.0319_ref3","doi-asserted-by":"crossref","unstructured":"Scherpereel A, Astoul P, Baas P, et al.: Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleura mesothelioma. Eur Repir J 2010; 35: 479\u201395.","DOI":"10.1183\/09031936.00063109"},{"key":"10.3238\/arztebl.2013.0319_ref4","doi-asserted-by":"crossref","unstructured":"Wagner J, Sleggs C, Marchand P: Diffuse pleural mesothelioma and asbestos exposure in the north western cape province. Brit J Ind Med 1960; 17: 260\u201371.","DOI":"10.1136\/oem.17.4.260"},{"key":"10.3238\/arztebl.2013.0319_ref5","doi-asserted-by":"crossref","unstructured":"Selikoff I, Churg J, Hammond E: Relation between exposure to asbestos and mesothelioma. N Eng J Med 1965; 272: 560\u20135.","DOI":"10.1056\/NEJM196503182721104"},{"key":"10.3238\/arztebl.2013.0319_ref6","doi-asserted-by":"crossref","unstructured":"Craighead J: Epidemiology of mesothelioma and historical background. Rec Res Cancer Res 2011; 189: 13\u201325.","DOI":"10.1007\/978-3-642-10862-4_2"},{"key":"10.3238\/arztebl.2013.0319_ref7","unstructured":"Hain E, Calavrezos A, Koschel G: Asbest und asbestbedingte Tumoren \u2013 Klinik und Diagnostik. Atemw Lungenerkrkh 1984; 10: 145\u201350."},{"key":"10.3238\/arztebl.2013.0319_ref8","doi-asserted-by":"crossref","unstructured":"Neumann V, L\u00f6seke S, Tannapfel A: Mesothelioma and analysis of tissue fiber content. Rec Res Cancer Res 2011; 189: 79\u201395.","DOI":"10.1007\/978-3-642-10862-4_6"},{"key":"10.3238\/arztebl.2013.0319_ref9","doi-asserted-by":"crossref","unstructured":"Champbell N, Kindler H: Update on malignant pleural mesothelioma. Semin Respir Crit Care Med 2011; 32: 102\u201310.","DOI":"10.1055\/s-0031-1272874"},{"key":"10.3238\/arztebl.2013.0319_ref10","doi-asserted-by":"crossref","unstructured":"Neumann V, G\u00fcnther S, M\u00fcller K, Fischer M: Malignant mesothelioma \u2013 German mesotheliom register 1987 \u2013 1999. Int Arch Occup Health 2001; 74: 383\u201395.","DOI":"10.1007\/s004200100240"},{"key":"10.3238\/arztebl.2013.0319_ref11","doi-asserted-by":"crossref","unstructured":"Gill R: Imaging of mesothelioma. Recent Res Cancer Res 2011; 189: 27\u201355.","DOI":"10.1007\/978-3-642-10862-4_3"},{"key":"10.3238\/arztebl.2013.0319_ref12","doi-asserted-by":"crossref","unstructured":"Reus J: Sonography of the pleura. Ultraschall Med 2010; 31: 8\u201322.","DOI":"10.1055\/s-0028-1109995"},{"key":"10.3238\/arztebl.2013.0319_ref13","unstructured":"Husain A, Colby T, Ordonez N, et al.: Guidelines for pathologic diagnosis of malignant mesothelioma. Arch Pathol Lab Med 2012; 136: 1\u201321."},{"key":"10.3238\/arztebl.2013.0319_ref14","doi-asserted-by":"crossref","unstructured":"Attanous R, Gibbs A: The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesothelioma. Histopathol 2006; 53: 340\u20134.","DOI":"10.1111\/j.1365-2559.2008.03099.x"},{"key":"10.3238\/arztebl.2013.0319_ref15","doi-asserted-by":"crossref","unstructured":"Hopper C, Lee Y, Maskell N: Investigation of a unilateral pleural effusion in adults. British Thoracic Society pleural disease guideline. Thorax 2010; 65; 4\u201317.","DOI":"10.1136\/thx.2010.136978"},{"key":"10.3238\/arztebl.2013.0319_ref16","doi-asserted-by":"crossref","unstructured":"Hasegawa S, Kondo N, Matsumoto S, et al.: Practical approaches to diagnose and treatment T0 malignant pleual mesothelioma: a proposal for diagnostic total parietal pleurectomy. Int J Clin Oncol 2012; 17: 33\u20139.","DOI":"10.1007\/s10147-011-0368-2"},{"key":"10.3238\/arztebl.2013.0319_ref17","doi-asserted-by":"crossref","unstructured":"Tischoff I, Neid M, Neumann V, Tannapfel A: Pathological diagnosis and differential diagnosis of mesothelioma. Rec Res Cancer Res 2011; 189: 57\u201377.","DOI":"10.1007\/978-3-642-10862-4_5"},{"key":"10.3238\/arztebl.2013.0319_ref18","unstructured":"Wittekind C, Meyer H: TNM Klassifikation maligner Tumoren. 7. Auflage. Weinheim: Wiley-VCH 2010."},{"key":"10.3238\/arztebl.2013.0319_ref19","doi-asserted-by":"crossref","unstructured":"Bielsa S, Hernandez P, Rodriguez-Pandero F, Taberna T, Salud A, Porcel J: Tumor type influence the effectiveness of pleurodesis in malignant effusions. Lung 2011; 189: 151\u20135.","DOI":"10.1007\/s00408-011-9283-6"},{"key":"10.3238\/arztebl.2013.0319_ref20","doi-asserted-by":"crossref","unstructured":"Rice D: Surgical therapy of mesothelioma. Recent Results Cancer Res 2011; 189: 97\u2013125.","DOI":"10.1007\/978-3-642-10862-4_7"},{"key":"10.3238\/arztebl.2013.0319_ref21","doi-asserted-by":"crossref","unstructured":"Soysal O, Karaoglanoglu N, Demiracan S: Pleurectomy\/decortication for palliation in malignant pleural mesothelioma. Results of surgery. Eur J Cardiothorac Surg 1997; 11: 210\u20133.","DOI":"10.1016\/S1010-7940(96)01008-1"},{"key":"10.3238\/arztebl.2013.0319_ref22","doi-asserted-by":"crossref","unstructured":"Treasure T, Lazdunski LL, Waller D, Bliss JM, Tan C, et al.: Extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 2011; 12: 763\u201372.","DOI":"10.1016\/S1470-2045(11)70149-8"},{"key":"10.3238\/arztebl.2013.0319_ref23","doi-asserted-by":"crossref","unstructured":"Gupta V, Krug L: Patterns of local and nodal failure in malignant pleural mesothelioma after extrapleural pneumectomy and photon electron radiotherapy. J Thorac Oncol 2009; 4: 746\u201350.","DOI":"10.1097\/JTO.0b013e3181a5292c"},{"key":"10.3238\/arztebl.2013.0319_ref24","doi-asserted-by":"crossref","unstructured":"Dhalluin X, Scherpereel A: Chemotherapy and Radiotherapy for mesothelioma. Rec Res Cancer Res 2011; 189: 127\u201347.","DOI":"10.1007\/978-3-642-10862-4_8"},{"key":"10.3238\/arztebl.2013.0319_ref25","doi-asserted-by":"crossref","unstructured":"Th\u00f6dtmann R, Depenbrock H, Dumez H, et al.: Clinical and pharmacokinetic phase I study of multitargeted antifolate (LY231514) in combination with cisplatin. J Clin Oncol 1999; 17: 3009\u201316.","DOI":"10.1200\/JCO.1999.17.10.3009"},{"key":"10.3238\/arztebl.2013.0319_ref26","doi-asserted-by":"crossref","unstructured":"Vogelzang N, Rusthoven J, Symanowski J, et al.: Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesotheliomna. J Clin Oncol 2003; 21: 2636\u201344.","DOI":"10.1200\/JCO.2003.11.136"},{"key":"10.3238\/arztebl.2013.0319_ref27","doi-asserted-by":"crossref","unstructured":"Grosso F, Scagliotti G: Systematic treatment of malignant pleural mesothelioma. Fut Oncol 2012; 8: 293\u2013305.","DOI":"10.2217\/fon.12.14"},{"key":"10.3238\/arztebl.2013.0319_ref28","doi-asserted-by":"crossref","unstructured":"Muers M, Stephens R, Fischer P: Active symptom control with or without chemotherapy in the treatment of patients with malignant mesothelioma: a multicentre randomised trial. Lancet 2008; 371: 1685\u201394.","DOI":"10.1016\/S0140-6736(08)60727-8"},{"key":"10.3238\/arztebl.2013.0319_ref29","doi-asserted-by":"crossref","unstructured":"Manegold C, Symanowski J, Gatzemeier U, et al.: Second line (post study) chemotherapy received by patients treated in the phase III trial pemetrexed plus cisplatin alone in malignant pleural mesothelioma. Ann Oncol 2005; 16: 923\u20137.","DOI":"10.1093\/annonc\/mdi187"},{"key":"10.3238\/arztebl.2013.0319_ref30","unstructured":"Laack E, Sch\u00fctte J, Dierkesmann R: Malignes Mesotheliom. Leitlinie der Deutschen Gesellschaft f\u00fcr H\u00e4matologie und Onkologie 2005. www.dgho-onkopedia.de\/de\/onkopedia\/archiv\/mesotheliom\/mesotheliom-stand-jul.2005"},{"key":"10.3238\/arztebl.2013.0319_ref31","doi-asserted-by":"crossref","unstructured":"Sienel W, Kirschbaum A, Passlick B: Multimodale Therapie des malignen Pleuramesothelioms einschlie\u00dflich der Pleuropneumektomie. Zentralbl Chir 2008; 133: 231\u20137.","DOI":"10.1055\/s-2008-1076790"},{"key":"10.3238\/arztebl.2013.0319_ref32","doi-asserted-by":"crossref","unstructured":"Sugarbaker D, Garcia J, Richards W: Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. Ann Surg 1996; 224: 288\u201394.","DOI":"10.1097\/00000658-199609000-00005"},{"key":"10.3238\/arztebl.2013.0319_ref33","doi-asserted-by":"crossref","unstructured":"Pass H, Levin S, Harbut M, et al.: Fibulin 3 as a blood and effusion biomarker for pleural mesothelioma. N Engl J Med 2012; 367: 1417\u201327.","DOI":"10.1056\/NEJMoa1115050"},{"key":"10.3238\/arztebl.2013.0319_ref34","doi-asserted-by":"crossref","unstructured":"Fascola G, Belvedere O, Aita M, et al.: Low dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos exposed population. Baseline results of a prospective nonrandomized feasibility trial\u2014an Alpe adria thoracic oncology multidisciplinary group study. 2007; Oncologist 12: 1215\u201324.","DOI":"10.1634\/theoncologist.12-10-1215"},{"key":"10.3238\/arztebl.2013.0319_ref35","doi-asserted-by":"crossref","unstructured":"Roberts H, Patsios D, Paul N, et al.: Screening for malignant pleural mesothelioma and lung cancer in individuals with a history of asbestos exposure. J Thorac Oncol 2009; 4: 620\u20138.","DOI":"10.1097\/JTO.0b013e31819f2e0e"},{"key":"10.3238\/arztebl.2013.0319_ref36","unstructured":"Ramac P, Hebrang A, Ivanovi-Herceg Z, et al.: The possibilities and limitations of direct digital radiography, ultrasound and computed tomography in diagnosing pleural mesothelioma. Coll Antropol 2010; 34: 1263\u201371."},{"key":"10.3238\/arztebl.2013.0319_ref37","doi-asserted-by":"crossref","unstructured":"Husain A, Colby T, Ordonez N, et al.: Guidelines for pathologic diagnosis of malignant mesothelioma. A consensus statement from the international mesothelioma interest group. Arch Pathol Lab Med 2009; 133: 1317\u201331.","DOI":"10.5858\/133.8.1317"},{"key":"10.3238\/arztebl.2013.0319_ref38","unstructured":"Falkensteiner Empfehlung: Empfehlung f\u00fcr die Begutachtung asbestbedingter Berufskrankheiten. Deutsche Gesetzliche Unfallversicherung e.V. (DGUV) Berlin 2011. http:\/\/publikationen.dguv.de\/dguv\/pdf\/10002\/falkensteinerempfehlung.pdf"},{"key":"10.3238\/arztebl.2013.0319_ref39","doi-asserted-by":"crossref","unstructured":"Baur X, Clasen M, Fisseler-Eckhoff A, et al.: AWMF Leitlinie: Diagnostik und Begutachtung asbestbedingter Berufskrankheiten. Interdisziplin\u00e4re S2-Leitlinie der Deutschen Gesellschaft f\u00fcr Pneumologie und Beatmungsmedizin und der Deutschen Gesellschaft f\u00fcr Arbeitsmedizin und Umweltmedizin. Pneumologie 2011; 65: e1\u2013e47.","DOI":"10.1055\/s-0030-1255992"},{"key":"10.3238\/arztebl.2013.0319_ref40","doi-asserted-by":"crossref","unstructured":"Hillerdal G: Mesothelioma: cases associated with non-occupational and low dose exposure. Occup Environ Med 1999; 56: 505\u201313.","DOI":"10.1136\/oem.56.8.505"},{"key":"10.3238\/arztebl.2013.0319_ref41","doi-asserted-by":"crossref","unstructured":"M\u00fcller K, Dernbach A, Neumann V: Mesotheliome bei Akademikern \u2013 Deutsches Mesotheliomregister in Bochum. Pathologe 2003; 24: 109\u201311.","DOI":"10.1007\/s00292-002-0561-1"},{"key":"10.3238\/arztebl.2013.0319_ref42","unstructured":"Nowak D, Huber R: Berufliche Risikofaktoren, Berufskrankheit, arbeitsmedizinische Begutachtung. 2009; www.tumorzentrum-muenchen.de."},{"key":"10.3238\/arztebl.2013.0319_ref43","doi-asserted-by":"crossref","unstructured":"Ramazzini C: Asbestos is still with us: Repeat call for a universal ban. Am J Ind Med 2011; 54: 168\u201373.","DOI":"10.1002\/ajim.20892"},{"key":"10.3238\/arztebl.2013.0319_ref44","unstructured":"Weiss S: Position Statement on asbestos from the Joint policy Committee of the Societies of Epidemiology (JPC-SE), 2012; www.jpc-se.org\/documents\/03.JPC-SE-Position_Statement_on_Asbestos-June_4_2012-Full_Statement_and_Appendix_A.pdf"},{"key":"10.3238\/arztebl.2013.0319_ref45","doi-asserted-by":"crossref","unstructured":"Iwatsubo Y, Parion J, Boutin C: Pleural mesothelioma: dose response relation in low levels of asbestos exposure in a French population based case control study. Am J Epidemiol 1998; 148: 133\u201342.","DOI":"10.1093\/oxfordjournals.aje.a009616"},{"key":"10.3238\/arztebl.2013.0319_ref46","doi-asserted-by":"crossref","unstructured":"Jasani B, Gibbs A: Mesothelioma not associated with asbestos exposure. Arch Pathol Lab Med 2012; 136: 262\u20137.","DOI":"10.5858\/arpa.2011-0039-RA"},{"key":"10.3238\/arztebl.2013.0319_ref47","doi-asserted-by":"crossref","unstructured":"Donaldson K, Murphy F, Duffin R, Poland C: Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol 2012; 7: 5.","DOI":"10.1186\/1743-8977-7-5"},{"key":"10.3238\/arztebl.2013.0319_ref48","doi-asserted-by":"crossref","unstructured":"Leigh J, Davidson P, Hendrie L, Berry D: Malignant mesothelioma in Australia, 1945\u20132000. Ann Occup Hyg 2002; 46: 160\u20135.","DOI":"10.1002\/ajim.10047"},{"key":"10.3238\/arztebl.2013.0319_ref49","doi-asserted-by":"crossref","unstructured":"Tan E, Warren N, Darnton AJ, Hodgson JT: Projection of mesothelioma mortality in Britain using Bayesian methods. Brit J Cancer 2010; 103: 430\u20136","DOI":"10.1038\/sj.bjc.6605781"},{"key":"10.3238\/arztebl.2013.0319_ref50","doi-asserted-by":"crossref","unstructured":"Pesch B, Taeger D, Johnen G, et al.: Cancer mortality in a surveillance cohort of German males formerly exposed to asbestos. Int J Hyg Environ Health 2010; 213: 44\u201351.","DOI":"10.1016\/j.ijheh.2009.09.001"},{"key":"10.3238\/arztebl.2013.0319_ref51","doi-asserted-by":"crossref","unstructured":"Peto J, Decarli A, Vecchia CL, Levi F, Negri E: The European mesothelioma epidemic. Brit J Cancer 1999; 666\u201372.","DOI":"10.1038\/sj.bjc.6690105"},{"key":"10.3238\/arztebl.2013.0319_ref52","doi-asserted-by":"crossref","unstructured":"Banaei A, Auvert B, Goldberg M, Gueguen A, Luce D, Goldberg S: Future trends in mortality of French men from mesothelioma. Occup Environ Med 2000; 57: 488\u201394.","DOI":"10.1136\/oem.57.7.488"},{"key":"10.3238\/arztebl.2013.0319_ref53","doi-asserted-by":"crossref","unstructured":"Larson T, Melnikova N, Davis SI, Jamison P: Incidence and descriptive epidemiology of mesothelioma in the United States, 1999 \u2013 2002. Int J Occup Environ Health 2007; 13: 398\u2013403.","DOI":"10.1179\/oeh.2007.13.4.398"},{"key":"10.3238\/arztebl.2013.0319_ref54","doi-asserted-by":"crossref","unstructured":"Azuma K, Uchiyama I, Yasutaka C, Okumura J: mesothelioma risk and environmental exposure to asbestos. Int J Occup Environ Health 2009; 15: 166\u201372.","DOI":"10.1179\/oeh.2009.15.2.166"},{"key":"10.3238\/arztebl.2013.0319_ref55","doi-asserted-by":"crossref","unstructured":"Pitarque S, Cleries R, Martinez JM, Lopez-Abente G, Kogevinas, Benavides FG: mesothelioma mortality in men: trends during 1977\u20132001 and projections for 2002\u20132016 in Spain. Occup Environ Med 2008; 65: 279\u201382.","DOI":"10.1136\/oem.2007.034769"},{"key":"10.3238\/arztebl.2013.0319_ref56","doi-asserted-by":"crossref","unstructured":"Segura O, Burdorf A, Looman C: Update of predictions of mortality from pleural mesothelioma in the Netherlands. Occup Environ Med 2003; 60: 50\u20135.","DOI":"10.1136\/oem.60.1.50"},{"key":"10.3238\/arztebl.2013.0319_ref57","doi-asserted-by":"crossref","unstructured":"Schipper PH, Nichols FC, Thomse KM, Deschamps C, Cassivi SD, Allen MS, Pairolero PC: Malignant pleural mesothelioma: surgical management in 285 patients. Ann Thorac Surg 2008; 85: 257\u201364.","DOI":"10.1016\/j.athoracsur.2007.06.066"},{"key":"10.3238\/arztebl.2013.0319_ref58","doi-asserted-by":"crossref","unstructured":"Nakas A, Trousse DS, Martin-Ucar AE, Waller DA: Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodal therapy. Eur J Cardiothorac Surg 2008; 34: 886\u201391.","DOI":"10.1016\/j.ejcts.2008.06.010"},{"key":"10.3238\/arztebl.2013.0319_ref59","doi-asserted-by":"crossref","unstructured":"Halstead JC, Lim E, Venkateswaran RM, Charman SC, Goddard M, Ritchie AJ: Improved survival with VATS pleurectomy-decortication in advanced malignant mesothelioma. Eur J Surg Oncol 2005; 31: 314\u201320.","DOI":"10.1016\/j.ejso.2004.08.014"},{"key":"10.3238\/arztebl.2013.0319_ref60","doi-asserted-by":"crossref","unstructured":"Nakas A, von Meyenfeldt E, Lau K, Muller S, Waller D: Long-term survival after lung-sparing total pleurectomy for locally advanced (International Mesothelioma Interest Group Stage T3-T4) non-sarcomatoid malignant pleural mesothelioma. Eur J Cardiothorac Surg 2012; 41: 1031\u20136.","DOI":"10.1093\/ejcts\/ezr192"},{"key":"10.3238\/arztebl.2013.0319_ref61","doi-asserted-by":"crossref","unstructured":"Okada M, Mimura T, Ohbayashi C, Sakuma T, Soejima T, Tsubota N: Radical surgery for malignant pleural mesothelioma: results and prognosis. Intera CardioVasc and Thorac Surg 2008; 7: 102\u20136.","DOI":"10.1510\/icvts.2007.166322"},{"key":"10.3238\/arztebl.2013.0319_ref62","doi-asserted-by":"crossref","unstructured":"Maziak DE, Gagliardi A, Haynes AE, Mackay JA, Evans WK, Cancer Care Ontario Program in Evidence-based Care Lung Cancer Disease Site Group: Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary. Lung Cancer 2005; 48: 157\u201369.","DOI":"10.1016\/j.lungcan.2004.11.003"},{"key":"10.3238\/arztebl.2013.0319_ref63","doi-asserted-by":"crossref","unstructured":"Aziz T, Jilaihawi A, Prakash D: The management of malignant pleural mesothelioma; single centre experience in 10 years. Eur J Cardiothorac Surg 2002; 22: 298\u2013305.","DOI":"10.1016\/S1010-7940(02)00273-7"},{"key":"10.3238\/arztebl.2013.0319_ref64","doi-asserted-by":"crossref","unstructured":"Ambrogi V, Baldi A, Schillaci O, Mineo TC: Clinical impact of extrapleural pneumonectomy for malignant pleural mesothelioma. Ann Surg Oncol 2012; 19: 1692\u20139.","DOI":"10.1245\/s10434-011-2171-8"},{"key":"10.3238\/arztebl.2013.0319_ref65","doi-asserted-by":"crossref","unstructured":"Flores RM, Pass HI, Seshan VE, et al.: Extrapleural pneumonectomy versus pleurectomy\/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 2008; 135: 620\u20136.","DOI":"10.1016\/j.jtcvs.2007.10.054"},{"key":"10.3238\/arztebl.2013.0319_ref66","doi-asserted-by":"crossref","unstructured":"Aigner C, Hoda MAR, Lang G, Taghavi, S, Marta G, Klepetko W: Outcome after extrapleural pneumonectomy for malignant pleural mesothelioma. Eur J Cardiothoracic Surg 2008; 34: 204\u20137.","DOI":"10.1016\/j.ejcts.2008.03.003"},{"key":"10.3238\/arztebl.2013.0319_ref67","doi-asserted-by":"crossref","unstructured":"Yan TD, Boyer M, Tin MM, et al.: Extrapleural pneumonectomy for malignant pleural mesothelioma: Outcomes of treatment and prognostic factors. Gen Thorac Surg 2009; 138: 619\u201324.","DOI":"10.1016\/j.jtcvs.2008.12.045"},{"key":"10.3238\/arztebl.2013.0319_ref68","doi-asserted-by":"crossref","unstructured":"Treasure T, Lang-Lazdunski L, Waller D, et al. for the MARS trialists: Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 2011; 12: 763\u201372.","DOI":"10.1016\/S1470-2045(11)70149-8"},{"key":"10.3238\/arztebl.2013.0319_ref69","doi-asserted-by":"crossref","unstructured":"Nakas A, Martin Ucar AE, Edwards JG, Waller DA: The role of video assisted thoracoscopic pleurectomy\/decortication in the therapeutic management of malignant pleural mesothelioma. Eur J Cardiothorac Surg 2008; 33: 83\u20138.","DOI":"10.1016\/j.ejcts.2007.09.039"},{"key":"10.3238\/arztebl.2013.0319_ref70","doi-asserted-by":"crossref","unstructured":"Hillerdal G, Sorensen JB, Sundstr\u00f6m S, Riska H, Vikstr\u00f6m A, Hjerpe A: Treatment of malignant pleural mesothelioma with Carboplatin, liposomized Doxorubicin and Gemcitabine. J Thorac Oncol 2008; 3: 1325\u201331.","DOI":"10.1097\/JTO.0b013e31818b174d"},{"key":"10.3238\/arztebl.2013.0319_ref71","doi-asserted-by":"crossref","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, et al.: Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003; 21: 2636\u201344.","DOI":"10.1200\/JCO.2003.11.136"},{"key":"10.3238\/arztebl.2013.0319_ref72","doi-asserted-by":"crossref","unstructured":"Metintas M, Ak G, Erginel S, Alatas F, Yildirim H, Kurt E, Metintas S: A retrospective analysis of malignant pleural mesothelioma patients treated either with chemotherapy or best supportive care between 1990 and 2005. A single institution experience. Lung Cancer 2007; 55: 379\u201387.","DOI":"10.1016\/j.lungcan.2006.11.005"},{"key":"10.3238\/arztebl.2013.0319_ref73","doi-asserted-by":"crossref","unstructured":"van Meerbeeck JP, Gaafar R, Manegold C, et al.: European Organisation for Research and Treatment of Cancer Lung Cancer Group, National Cancer Institute of Canada: Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma. J Clinic Oncol 2005; 23: 6881\u20139.","DOI":"10.1200\/JCO.20005.14.589"},{"key":"10.3238\/arztebl.2013.0319_ref74","doi-asserted-by":"crossref","unstructured":"Knuuttila A, Salomaa ER, Saikkonen S, Hurme S, Salo J: Pemetrexed in malignant pleural mesothelioma and the clinical outcome. Clin Respir J 2012; 6: 96\u2013103.","DOI":"10.1111\/j.1752-699X.2011.00252.x"},{"key":"10.3238\/arztebl.2013.0319_ref75","doi-asserted-by":"crossref","unstructured":"Muers MF, Stephens RJ, Fisher P, et al.: MS01 Trail Management Group: active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trail. Lancet 2008; 371: 1685\u201394.","DOI":"10.1016\/S0140-6736(08)60727-8"},{"key":"10.3238\/arztebl.2013.0319_ref76","doi-asserted-by":"crossref","unstructured":"Rice DC, Stevens CW, Correa AM, et al.: Outcomes after extrapleural pneumonectomy and intensy-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg 2007; 84: 1685\u201392.","DOI":"10.1016\/j.athoracsur.2007.04.076"},{"key":"10.3238\/arztebl.2013.0319_ref77","doi-asserted-by":"crossref","unstructured":"Rosenzweig KE, Zauderer MG, Laser B, et al.: Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2012; 83: 1278\u201383.","DOI":"10.1016\/j.ijrobp.2011.09.027"},{"key":"10.3238\/arztebl.2013.0319_ref78","doi-asserted-by":"crossref","unstructured":"Rusch VW, Rosenzweig K, Venkatraman E, et al.: A phase II trail of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2001; 122: 788\u201395.","DOI":"10.1067\/mtc.2001.116560"},{"key":"10.3238\/arztebl.2013.0319_ref79","doi-asserted-by":"crossref","unstructured":"Gupta V, Mychalczak B, Krug L, et al.: Hemithoracic radiation therapy after pleurectomy\/decortication for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2005; 63: 1045\u201352.","DOI":"10.1016\/j.ijrobp.2005.03.041"},{"key":"10.3238\/arztebl.2013.0319_ref80","doi-asserted-by":"crossref","unstructured":"Lang-Lazdunski L, Bille A, Belcher E, et al.: Pleurectomy\/decortication, hyperthermic pleural lavage with povidone-iodine followed by adjuvant chemotherapy in patients with malignant pleural mesothelioma. J Thorac Oncol 2011; 6: 1746\u201352.","DOI":"10.1097\/JTO.0b013e3182288af9"},{"key":"10.3238\/arztebl.2013.0319_ref81","doi-asserted-by":"crossref","unstructured":"Bille A, Belcher E, Raubenheimer H, et al.: Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy`s and St Thomas` hospitals. Gen Thorac Cardiovasc Surg 2012; 60: 289\u201396.","DOI":"10.1007\/s11748-011-0915-9"},{"key":"10.3238\/arztebl.2013.0319_ref82","doi-asserted-by":"crossref","unstructured":"Sugarbaker DJ, Flores RM, Jaklitsch MT, et al.: Resection margins, extrapleural nodal status and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999; 117: 54\u201363.","DOI":"10.1016\/S0022-5223(99)70469-1"},{"key":"10.3238\/arztebl.2013.0319_ref83","doi-asserted-by":"crossref","unstructured":"Krug LM, Pass HI, Rusch VW, et al.: Multicenter phase II trail of neoadjuvant Pemetrexed plus Cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clinic Oncol 2009; 27: 3007\u201313.","DOI":"10.1200\/JCO.2008.20.3943"},{"key":"10.3238\/arztebl.2013.0319_ref84","doi-asserted-by":"crossref","unstructured":"van Schil PE, Baas P, Gaafar R, et al. on behalf of the European Organisation for research and Treatment of Cancer (EORTC) Lung Cancer Group: Trimodal therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trail. Eur Respir J 2010; 36: 1362\u20139.","DOI":"10.1183\/09031936.00039510"},{"key":"10.3238\/arztebl.2013.0319_ref85","doi-asserted-by":"crossref","unstructured":"Weder W, Stahel RA, Bernhard J, et al. on behalf of the Swiss Group for Clinical Cancer Research. Ann Oncol 2007; 18: 1196\u201302.","DOI":"10.1093\/annonc\/mdm093"},{"key":"10.3238\/arztebl.2013.0319_ref86","doi-asserted-by":"crossref","unstructured":"Patel PR, Yoo S, Broadwater G, et al.: Effect of increasing experience on dosimetric and clinical outcomes on the management of malignant pleural mesothelioma with intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2012; 83: 362\u20138.","DOI":"10.1016\/j.ijrobp.2011.11.057"},{"key":"10.3238\/arztebl.2013.0319_ref87","doi-asserted-by":"crossref","unstructured":"B\u00f6l\u00fckbas S, Manegold C, Eberlein M, Bergmann T, Fisseler-Eckhoff A, Schirren J: Survival after trimodality therapy for malignant pleural mesothelioma: Radical pleurectomy, chemotherapy with Cisplatin\/Pemetrexed and radiotherapy. Lung Cancer 2011; 71: 75\u201381.","DOI":"10.1016\/j.lungcan.2009.08.019"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2013.0319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T08:42:47Z","timestamp":1638780167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2013.0319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,3]]},"references-count":87,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2013.0319","relation":{"is-cited-by":[{"id-type":"doi","id":"10.1007\/s12064-017-0256-z","asserted-by":"object"},{"id-type":"doi","id":"10.1007\/978-3-319-69641-6_3","asserted-by":"object"}]},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,3]]}}}